DEADLINE NEXT WEEK: Berger Montague Advises Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Investors to Contact the Firm Before March 10, 2025
Portfolio Pulse from
Berger Montague PC has filed a lawsuit against Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on behalf of investors who purchased securities between November 2, 2023, and October 30, 2024. Investors are advised to contact the firm before March 10, 2025.
March 03, 2025 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
A lawsuit has been filed against Regeneron Pharmaceuticals, Inc. for securities purchased between November 2, 2023, and October 30, 2024. Investors should contact Berger Montague PC by March 10, 2025.
The lawsuit could negatively impact Regeneron's stock price as it may lead to financial liabilities or reputational damage. The deadline for investors to act is March 10, 2025, which adds urgency to the situation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100